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Wednesday, February 29, 2012 621atechniques including MALS (Multi-Angle Light Schattering), X-ray crystal-
lographyic, and SAXS (Small Angle X-ray Scattering) to better understand
the nature of the active conformation of GAC and ultimately, how the recently
described glutaminase inhibitor 968 (J.B., Wang; Cancer Cell, 2010) interacts
with GAC and renders it inactive. Our results support a model whereby GAC
binds phosphate that results in a change in glutaminase oligomerization,
which results in active tetramers as well as higher oligomeric species. Effects
of the drug 968 on the activation/oligomerization state of glutaminase will
also be discussed.
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Structure-based design efforts on antibodies are frequently hamstrung by the
general difficulty of crystallizing antibody molecules. Computational ap-
proaches are getting more success and playing a very important role in protein
structure prediction and design. A combined platform with both computational
predication and experimental verification would have a transformative research
capability on antibody engineering. We have been developing and integrating
RosettaAntibody (homology modeling and H3 loop modeling), RosettaDock
(SnugDock and EnsembleDock) and RosettaDesign (non-canonical amino
acids design) into a systematic computational pipeline. Using the targets of
M18/Anthrax complex, which has solved crystal structure, and anti-MS2/
MS2 complex, whose antibody structure is not available, the new pipeline is
capable of building homology models for antibody from its sequence, and pre-
dicting the docked antibody-antigen structures. The correct antigen epitope can
be identified by iteratively refining the predicted candidates with experimental
verifications such as interface alanine scanning. This is followed by computa-
tional CDR designs utilizing non-canonical amino acids, which can form cova-
lent bonds with epitope residues. Along with experimental confirmations, the
incorporation of the systematical computational method was proved to signif-
icantly facilitate the epitope identification and non-canonical amino acid de-
signs. These efforts eventually substantially increased the antibody-antigen
binding affinity of the two targets.
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The envelope spike on HIV surface is a non-covalent trimer of gp120 and
gp41 dimers; with gp120 responsible for binding to the CD4 receptor and
the mandatory coreceptor, CCR5 or CXCR4. Blocking the gp120-CD4 or
gp120-coreceptor interaction can block viral entry and infection. The HNG
family of peptides (sequence RINNIXWSEAMM, X= derivatized azidopro-
line) is a promising class of dual-site entry inhibitors thought to allosterically
inhibit the binding process and trap the flexible gp120 molecule in an inac-
tive state. To date, there have been no reports on the structure of the peptide
or the peptide/gp120 complex. Here we have used Molecular Dynamics to
develop a docking model in which the peptide binds in a tripartite fashion,
preventing the formation of the bridging sheet in gp120, which is necessary
for coreceptor attachment and initiation of entry. The protein undergoes sig-
nificant induced fit conformational changes involving movement of large
loops which allows the peptide to bind tightly. Our model is consistent
with experimental observations on the peptide footprint on gp120, pointing
to a hydrophobic core underneath the bridging sheet and close to the F43
pocket as the putative binding site. Our results provide an explanation for
why the stereochemistry of the triazole moiety on the proline is important
for peptide function, in addition to explaining the inactivity of D-tryptophan
in the sequence. Furthermore, saturation transfer difference (STD) NMR ex-
periments point to the I-X-P hydrophobic center on the peptide as the central
contact point in the complex, which is consistent with the peptide pose pro-
posed in MD studies. Our model may provide a unique basis for rational de-
sign of allosteric entry inhibitors of HIV and ultimately small molecule
inhibitors of viral entry.3153-Pos Board B14
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HIV-1 protease is an important drug target for the therapy of AIDS. Up to date
nine protease drugs have been approved by the U.S. Food and Drug Adminis-
tration. However, the efficacy of these drugs is limited by the drug-resistant
mutants of the protease which can become dominant in the viral population
in several months. As it often takes years of effort and millions of dollars to de-
velop a drug, evaluating the potency of a compound to combat resistance at the
early stage of drug development would is no doubt invaluable. In this study, we
present a new procedure to predict HIV protease mutants that can be resistant to
a specific compounds based on docking structure. We exploited molecular in-
teraction energy components (MIECs) between the ligand and the protease res-
idues to characterize the docking poses. A classification method called Support
Vector Machine (SVM) is then employed to distinguish resistant from non-
resistant mutants. Most interestingly, leave-one-drug-out test showed that our
strategy can be generalized to evaluate potency of new drug lead, which sug-
gests the possibility of evaluating the potency to combat resistance for small
molecules found from virtual screening.
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The objective of this study is to transport resveratrol, an antioxidant and anti-
inflammatory bioflavonoid, in the plasma to targeted sites. Resveratrol is a phy-
toalexin polyphenol that is found in natural products such as grape skins, cocoa,
and is a constituent of red wine. It appears to be a potent factor as an anti-cancer
and atheroprotective agent. The ‘‘French Paradox’’ (French suffering a rela-
tively lower incidence of coronary heart disease compared to other western so-
cieties) has been attributed to the benefits of resveratrol (as a result of higher
consumption of red wine by the French). However, it is difficult to achieve ef-
fective concentrations of resveratrol in plasma via the oral tract from natural
resveratrol-rich products. Its low aqueous solubility appears to limit the use
of resveratrol as a nutraceutical agent. We propose to employ apolipoprotein
E3 (apoE3)-containing reconstituted high density lipoproteins (rHDL) for
transportation and targeted delivery of resveratrol. rHDL are water soluble li-
poprotein complexes composed of a bilayer of phospholipids surrounded by
apoE3, which bears high affinity binding sites for the cell surface localized
low density lipoprotein receptor (LDLr). The phospholipid microenvironment
of rHDL is expected to provide a centrally located lipid milieu into which re-
sveratrol may be sequestered, and shielded from modification and/or degrada-
tion. Our data indicates that resveratrol has effectively partitioned into the
hydrophobic milieu of the phospholipid bilayer of rHDL without significant al-
teration to the conformation of apoE3. Importantly, the presence of resveratrol
did not alter the LDLr binding ability of apoE3. These results indicate that
rHDL bearing the apoE3 LDLr binding domain can serve as an effective
‘‘nanovehicle’’ to transport and potentially deliver resveratrol to targeted sites
across the cell membrane.
Funded by CSUPERB and TRDRP 17RT-0165.
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Insulin replacement therapy is central to the treatment of Type 1 diabetes mel-
litus (T1DM). Clinical trials have shown that tight glycemic control in T1DM
leads to reduction in long-term diabetic complications. In an effort to better
mimic the normal post-prandial pattern of pancreatic insulin release, meal-
time insulin analogs were developed in the 1990s using standard mutagenesis.
These analogs exhibit more rapid absorption from the subcutaneous depot due
to destabilization of the zinc insulin hexamer. Unfortunately, such conventional
analogs do not achieve the rapid ‘‘on-off’’ pharmacodynamic profiles sought in
an ideal rapid-acting insulin formulation. To circumvent this limitation, we
have investigated the utility of nonstandard protein design based on unnatural
mutagenesis. Our studies have focused on residue PheB24 at the dimer inter-
face of the insulin hexamer. Investigation of the role of this aromatic side
chain by hybrid quantum-mechanical/classical molecular mechanics (QM/
cMM) suggested that substitution of the B24 aromatic ring of its saturated
622a Wednesday, February 29, 2012near-isostere (cyclohexanylalanine; Cha) would introduce a subtle perturbation
but still allow hexamer formation. We therefore undertook the characterization
of a ChaB24-containing derivative of insulin lispro, the active component of
Humalog. Native-like assembly of phenol-stabilized insulin analog hexamers
was demonstrated in cobalt complexes by atomic absorption spectroscopy
and explicitly visualized in zinc complexes by X-ray crystallography.
ChaB24-lispro-insulin exhibits native hypoglycemic potency as measured in
Lewis rats rendered diabetic by steptozotocin. Preliminary studies of pharma-
codynamics in anesthetized Yorkshire pigs suggest that treatment of patients
with ChaB24-lispro-insulin may benefit from curtailment of the late post-
prandial ‘‘tail’’ of unwanted insulin action that presently confers risk of hypo-
glycemia. Together, these results exemplify the potential power of unnatural
amino acids to optimize the therapeutic properties of a protein central to the
treatment of a human disease.
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The side effects of therapeutic agents remain a major limiting factor in cancer
therapy. Targeting of cancerous cells using drug-delivering nano-carriers has
proved a promising avenue for improving agent specificity. To make further
progress it is imperative to determine design principles that maximize the spec-
ificity. With this goal, we theoretically study a generalized model of drug-
delivering nanocarriers binding to cancerous and healthy cells. We parametrize
the phase space by endocytosis rate, association/disassociation rate and ligand
number; and we investigate it for a variety of endocytosis profiles and drug de-
livery protocols. Our numerical and analytical results, supported by Monte-
Carlo simulations, show that counter-intuitively, specificity increases by sev-
eral orders of magnitude if the association rate values are close to the disasso-
ciation rate and the endocytosis rate value is relatively small. This optimal
region in design space is broadly robust across endocytosis profiles and drug-
delivery protocols.Membrane Protein Function II
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Recently, there has been a surge in elastic network model (ENM) parametriza-
tions using molecular dynamics (MD) simulations. These simple, coarse-
grained models represent proteins as beads connected by harmonic springs.
The motions of this system are then elucidated by normal mode analysis.
The goal of these recent parametrizations is to use MD to optimize predicted
motions. In this study, we optimize many ENM functional forms using a uni-
form dataset containing only long MD simulations. Our results show that,
across all models tested, residues neighboring in sequence adopt spring con-
stants that are orders of magnitude stiffer than more distal contacts. In addition,
the statistical significance of ENM performance varied with model resolution.
We also show that fitting long trajectories does not improve ENM performance
due to a problem inherent in all network models tested: they underestimate the
relative importance of the most concerted motions. Finally, we characterize
ENMs resilience to parametrization by tessellating the parameter space. Taken
together our data reveals that choice of spring function and parameters are not
vital to performance of a network model and that simple parameters can by de-
rived ‘‘by hand’’ when no data is available for fitting, thus illustrating the ro-
bustness of the models.
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Experimental and computational studies have shown that cellular membranes
deform to stabilize the inclusion of transmembrane (TM) proteins. Recent anal-
ysis suggests that membrane bending helps to expose charged and polar amino
acids to the aqueous environment and polar phospholipid headgroups. Our pre-
vious study used elasticity theory to characterize the distortions of a membrane
in the presence of a TM peptide. Here, we extend our method through the im-
plementation of a search algorithm that identifies the membrane shape that min-imizes the free energy of helix insertion. We show that our model robustly
identifies the hydrophobic stretch of a TM protein and allows for large defor-
mations to embed these stretches in the membrane. When applied to the
MscL stretch activated channel, our model predicts local membrane thinning
at the protein boundary that is corroborated by fluorescence and cysteine scan-
ning experiments. We go on to show that the insertion energy for proteins con-
taining multiple charged residues is non-additive, and the model provides
a clear physical mechanism for this non-additivity, which is absent in other con-
tinuum membrane models. We predict that some highly charged S4 segments
from voltage-gated Kþ channels are stable in the bilayer in accordance with
previous experiments and molecular dynamics simulations. Our method thus
captures essential aspects of protein-membrane interactions at a small fraction
of the cost of traditional molecular simulations.
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The structural similarity between many G-protein coupled receptors and their
extraordinary relevance for drug development sparks significant interest in their
activation mechanism and dynamics. Rhodopsins play an especially important
role in experimental studies, because their activation can be triggered in a very
controlled way via photoexcitation of the covalently bound cofactor retinal.
The successful crystallization of intermediates along the pathway to activation,
which were trapped using low temperatures and specific lipid environments,
provides a detailed view of some of the initial steps occurring on the picosecond
to nanosecond timescale. However, structural information for later intermedi-
ates, appearing on the microsecond to millisecond timescale, is still limited.
Developments of new computational platforms now allow the challenging
timescale ranging from 1-10 microseconds to be explored with atomistic com-
puter simulations. Here we report on a set of molecular dynamics simulations of
squid rhodopsin for which crystal structures of activation intermediates have
begun to be available recently (e.g., 3AYM in the PDB). Our simulations start
from a model of the batho state right after the photoexcitation and describe the
structural evolution over a timescale of 5.5 microseconds, allowing us to ob-
serve the formation of the meta-I preactivated state featuring significant defor-
mations of helices V and VI. Besides obtaining structural information,
observing the dynamics of the structural transitions allows us to identify a reac-
tion coordinate for the activation mechanism. By comparing simulations with
different force field parameters for the retinal cofactor, we also obtain addi-
tional information on the coupling of specific degrees of freedom of the retinal
to the rest of protein.
This work was supported by the NSF (grant CHE-0750175). We are grateful for
an allocation of computer time on Anton at the Pittsburgh Supercomputing
Center (supported by the NIH).
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In Escherichia coli TolC functions as an efflux duct interacting with various in-
ner membrane translocases including the multi-drug efflux pump AcrB. To in-
vestigate TolC wild-type dynamics, we performed five 150ns molecular
dynamics simulations of TolC in a phospholipid / water environment. One
run was extended to 300ns in two unmodified, and two modified simulations
deleting four sodium ions from the periplasmic bottlenecks region in one exten-
sion and removing all NaCl in the other. Whereas the inner periplasmic bottle-
neck I (BNI) outlined by Asp374 remained closed, opening and closing motions
in an outer bottleneck (BNII) near Gly365 were observed in all unmodified sim-
ulations. In the extended simulation a consecutive binding of two sodium ions
between BNII and BNI induces BNII closure. Although the removal of four so-
dium ions had no impact on the closed state of BNI and BNII, the complete de-
letion of all NaCl caused an opening of both bottlenecks. On extracellular side
we observe in all runs distinctive opening and closing motions, which might
hint at a novel way of action for drugs specifically targeting the TolC interior.
To gain insight into TolC-AcrB interaction, we performed five 150ns MD sim-
ulations of TolC and the AcrB docking-domain (AcrB_dd). Initially placed
1nm away from TolC and identically oriented as in the AcrAB-TolC-
Symmons docking structure, AcrB_dd docked to TolC within 10ns in one
run. Extending this simulation to 1ms, we found an TolC-AcrB_dd docking in-
terface characterized by a larger contact area and a slight asymmetry not
